CONCOMITANT DISEASE PROGRESSION side effect
What is CONCOMITANT DISEASE PROGRESSION ?Drugs associated with CONCOMITANT DISEASE PROGRESSION
CORDARONE CYCLOSPORINE DACOGEN DEPOCYT ENBREL ENTACAPONE EXJADE FEMARA GLEEVEC LOTREL LUCENTIS NEORAL SANDOSTATIN SIROLIMUS TIGECYCLINE TYSABRI VELCADE ZOLEDRONICCONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5586367-X
Physician from UNITED STATES reported ZOLEDRONIC ACID problem on Jan 10, 2008. Female patient, 77 years of age, weighting 138.9 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, leg amputation, neuropathic arthropathy, osteomyelitis, prosthesis implantation, skin ulcer, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, VITAMIN D, CALCIUM GLUCONATE. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Tysabri Side Effects Report #5605615-0
TYSABRI problem was reported by a Health Professional from on Jan 08, 2008. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, knee arthroplasty, osteoarthritis, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Sirolimus Side Effects Report #5555047-9
Physician from UNITED STATES reported SIROLIMUS problem on Dec 03, 2007. Male patient, 51 years of age, was diagnosed with focal segmental glomerulosclerosis and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, focal segmental glomerulosclerosis, . SIROLIMUS dosage: unknown. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5562730-8
ZOLEDRONIC ACID problem was reported by a Physician from BELGIUM on Dec 15, 2007. Female patient, 78 years of age, weighting 172.0 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, necrosis, osteomyelitis, toe amputation, toe operation, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, VITAMIN D, CALCIUM CARBONATE. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5562732-1
Physician from BELGIUM reported ZOLEDRONIC ACID problem on Dec 15, 2007. Male patient, 68 years of age, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, gastroenteritis, hip arthroplasty, hip dysplasia, intestinal obstruction, osteoarthritis, osteonecrosis, pain in extremity, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, VITAMIN D, CALCIUM CARBONATE, STEOVIT D, BUSCOPAN. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5563357-4
ZOLEDRONIC ACID problem was reported by a Physician from CZECH REPUBLIC on Dec 17, 2007. Female patient, 78 years of age, weighting 154.3 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, coronary artery disease, pulmonary embolism, ventricular arrhythmia, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM CARBONATE, VITAMIN D. Patient died on 01/29/2006.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5566117-3
Physician from FINLAND reported ZOLEDRONIC ACID problem on Dec 19, 2007. Male patient, 51 years of age, weighting 216.1 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, diabetes mellitus, osteomyelitis, pyrexia, sepsis, toe amputation, wound, wound infection, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM CARBONATE, VITAMIN D. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5568347-3
ZOLEDRONIC ACID problem was reported by a Physician from CANADA on Dec 20, 2007. Male patient, 70 years of age, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, hypertension, knee arthroplasty, osteoarthritis, post procedural complication, . ZOLEDRONIC ACID dosage: 5 MG Q 12 MONTHS. During the same period patient was treated with ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Femara Side Effects Report #5573288-1
Physician from FRANCE reported FEMARA problem on Dec 20, 2007. Female patient, 56 years of age, weighting 143.3 lb, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, pemphigoid, pruritus genital, rash papular, skin lesion, . FEMARA dosage: unknown. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5510976-7
ZOLEDRONIC ACID problem was reported by a Physician from ARGENTINA on Nov 08, 2007. Female patient, 86 years of age, weighting 143.3 lb, was diagnosed with osteoporotic fracture, tachyarrhythmia and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, cough, leukocytosis, neutrophilia, postoperative wound infection, pyrexia, staphylococcal infection, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with VITAMIN D, CALCIUM CARBONATE, ATLANSIL. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Dacogen Side Effects Report #5463613-4
Physician from UNITED STATES reported DACOGEN problem on Sept 11, 2007. Male patient, 69 years of age, weighting 152.1 lb, was diagnosed with myelodysplastic syndrome and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, idiopathic pulmonary fibrosis, respiratory failure, . DACOGEN dosage: unknown. During the same period patient was treated with PULMICORT, CRESTOR. Patient died on 08/31/2007.
CONCOMITANT DISEASE PROGRESSION : Lucentis Side Effects Report #5487243-3
LUCENTIS problem was reported by a Consumer or non-health professional from SWITZERLAND on Oct 05, 2007. Female patient was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, haematoma, . LUCENTIS dosage: 0.05 ML, UNK. During the same period patient was treated with AVASTIN. Patient was hospitalized and became disabled. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Exjade Side Effects Report #5490532-X
Physician from FINLAND reported EXJADE problem on Oct 17, 2007. Female patient was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, . EXJADE dosage: unknown. Patient died.
CONCOMITANT DISEASE PROGRESSION : Exjade Side Effects Report #5491485-0
EXJADE problem was reported by a Physician from FINLAND on Oct 17, 2007. Female patient was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, . EXJADE dosage: unknown. Patient died.
CONCOMITANT DISEASE PROGRESSION : Cordarone Side Effects Report #5494503-9
Health Professional from FRANCE reported CORDARONE problem on Oct 16, 2007. Male patient was treated with CORDARONE. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, hyperthyroidism, left ventricular failure, normochromic normocytic anaemia, small cell carcinoma, . CORDARONE dosage: unknown. During the same period patient was treated with ANAFRANIL, INIPOMP, LYRICA. Patient was hospitalized. Patient died on 09/03/2007.
CONCOMITANT DISEASE PROGRESSION : Cordarone Side Effects Report #5498673-8
CORDARONE problem was reported by a Health Professional from FRANCE on Oct 17, 2007. Female patient was diagnosed with atrial fibrillation, arrhythmia, cardiac valve prosthesis user and was treated with CORDARONE. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, haematuria, international normalised ratio increased, uterine neoplasm, . CORDARONE dosage: unknown. During the same period patient was treated with ROCEPHIN, FLAGYL, LEVOTHYROX, COUMADIN, INNOHEP. Patient was hospitalized. Patient died on 03/24/2007.
CONCOMITANT DISEASE PROGRESSION : Dacogen Side Effects Report #5463613-4
Physician from UNITED STATES reported DACOGEN problem on Sept 11, 2007. Male patient, 69 years of age, weighting 152.1 lb, was diagnosed with myelodysplastic syndrome and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, pulmonary fibrosis, respiratory failure, . DACOGEN dosage: unknown. During the same period patient was treated with PULMICORT, CRESTOR. Patient died on 08/31/2007.
CONCOMITANT DISEASE PROGRESSION : Sandostatin Side Effects Report #5434307-6
SANDOSTATIN LAR problem was reported by a Physician from GERMANY on Aug 22, 2007. Male patient, 73 years of age, weighting 218.3 lb, was diagnosed with diabetic retinopathy and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, diabetic foot, peripheral vascular disorder, . SANDOSTATIN LAR dosage: unknown. During the same period patient was treated with LORZAAR, PENTOXIFYLLINE. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Sandostatin Side Effects Report #5440767-7
Physician from GERMANY reported SANDOSTATIN LAR problem on Aug 22, 2007. Male patient, 73 years of age, weighting 216.1 lb, was diagnosed with diabetic retinopathy and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, coronary angioplasty, silent myocardial infarction, . SANDOSTATIN LAR dosage: unknown. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Depocyt Side Effects Report #5650248-3
DEPOCYT problem was reported by a Physician from FRANCE on Feb 18, 2008. Female patient, 65 years of age, was diagnosed with central nervous system lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: cauda equina syndrome, concomitant disease progression, . DEPOCYT dosage: 50 MG, X4;. During the same period patient was treated with MABTHERA, CHLORAMINOPHEN, CORTICOSTEROID, TAHOR, AMILORIDE HYDROCHLORIDE, ALPRESS, MODOPAR. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Entacapone Side Effects Report #5670521-2
Physician from JAPAN reported ENTACAPONE problem on Mar 13, 2008. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease, gastric ulcer, dyspepsia, constipation and was treated with ENTACAPONE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, concomitant disease progression, dysphagia, insomnia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest, . ENTACAPONE dosage: 200MG QID (800MG/DAY). During the same period patient was treated with FAMOTIDINE, SEVEN EP, MUCOSTA, EC DOPARL, MAGNESIUM OXIDE, LECICARBON. Patient was hospitalized. Patient died on 09/29/2007.
CONCOMITANT DISEASE PROGRESSION : Velcade Side Effects Report #5641581-X
VELCADE problem was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, concomitant disease progression, enterocolitis, lymphocyte count decreased, neutrophil count decreased, oral herpes, pneumonia, protein total decreased, . VELCADE dosage: 2.00 MG, INTRAVENOUS; 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON, LEVOFLOXACIN, BAKTAR, LAXOBERON, SENNOSIDE A, PANTOSIN, PLATELETS. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Tigecycline Side Effects Report #5608744-0
Pharmacist from UNITED KINGDOM reported TIGECYCLINE problem on Jan 22, 2008. Male patient was diagnosed with acinetobacter infection and was treated with TIGECYCLINE. After drug was administered, patient experienced the following problems/side effects: acinetobacter infection, concomitant disease progression, condition aggravated, head injury, multi-organ failure, . TIGECYCLINE dosage: unknown. During the same period patient was treated with COLISTIN SULPHATE. Patient died on 01/01/2006.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5556890-2
ZOLEDRONIC ACID problem was reported by a Physician from ARGENTINA on Dec 14, 2007. Female patient, 56 years of age, weighting 179.7 lb, was diagnosed with osteoporotic fracture, type 2 diabetes mellitus, hypothyroidism and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: amputation, concomitant disease progression, diabetes mellitus, enterococcal infection, morganella infection, osteomyelitis, skin ulcer, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM CARBONATE, VITAMIN D, GLYBURIDE, LEVOTIROXINA. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5568333-3
Physician from CANADA reported ZOLEDRONIC ACID problem on Dec 20, 2007. Female patient, 77 years of age, weighting 144.4 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: cerebellar ataxia, concomitant disease progression, dyspnoea, fall, pneumonia, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, VITAMIN D, CELEXA, LORAZEPAM. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5568362-X
ZOLEDRONIC ACID problem was reported by a Physician from SWITZERLAND on Dec 20, 2007. Female patient, 68 years of age, weighting 103.6 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: arthralgia, concomitant disease progression, fall, femoral neck fracture, femur fracture, hip arthroplasty, joint dislocation, osteonecrosis, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM CARBONATE, VITAMIN D. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5573069-9
Physician from UNITED STATES reported ZOLEDRONIC ACID problem on Dec 18, 2007. Female patient, 67 years of age, weighting 200.6 lb, was diagnosed with breast cancer, osteoporosis and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: bone density decreased, concomitant disease progression, fall, open reduction of fracture, radius fracture, ulna fracture, upper limb fracture, . ZOLEDRONIC ACID dosage: 4MG EVERY 6 MONTHS. During the same period patient was treated with CALCIUM, VITAMIN D, FEMARA. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Lotrel Side Effects Report #5573697-0
LOTREL problem was reported by a Health Professional from UNITED STATES on Dec 18, 2007. Male patient, 69 years of age, weighting 169.3 lb, was diagnosed with hypertension, osteoarthritis, benign prostatic hyperplasia, diabetes mellitus and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema, concomitant disease progression, food allergy, swollen tongue, . LOTREL dosage: unknown. During the same period patient was treated with DITROPAN, NABUMETONE, PROSCAR, ASPIRIN, GLIPIZIDE. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Sirolimus Side Effects Report #5517396-X
Physician from UNITED KINGDOM reported SIROLIMUS problem on Nov 09, 2007. Female patient was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: chronic respiratory failure, concomitant disease progression, lower respiratory tract infection, . SIROLIMUS dosage: unknown. Patient was hospitalized. Patient died on 10/23/2007.
CONCOMITANT DISEASE PROGRESSION : Sirolimus Side Effects Report #5518619-3
SIROLIMUS problem was reported by a Physician from UNITED KINGDOM on Nov 09, 2007. Female patient was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: chronic respiratory failure, concomitant disease progression, lower respiratory tract infection, . SIROLIMUS dosage: unknown. Patient was hospitalized. Patient died on 10/23/2007.
CONCOMITANT DISEASE PROGRESSION : Gleevec Side Effects Report #5474355-3
Physician from JAPAN reported GLEEVEC problem on Sept 28, 2007. Female patient, 69 years of age, weighting 81.57 lb, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: completed suicide, concomitant disease progression, depression, insomnia, stress, . GLEEVEC dosage: 300 MG, QD. During the same period patient was treated with VITAMEDIN S, GASMOTIN, DAIOU, KAMAG, FERROMIA, CATLEP, TOLEDOMIN. Patient died on 03/29/2006.
CONCOMITANT DISEASE PROGRESSION : Gleevec Side Effects Report #5474459-5
GLEEVEC problem was reported by a Physician from JAPAN on Sept 28, 2007. Female patient, 69 years of age, weighting 81.57 lb, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: completed suicide, concomitant disease progression, depression, insomnia, stress, . GLEEVEC dosage: 300 MG, QD. During the same period patient was treated with VITAMEDIN S, GASMOTIN, DAIOU, KAMAG, FERROMIA, CATLEP, TOLEDOMIN. Patient died on 03/29/2006.
CONCOMITANT DISEASE PROGRESSION : Entacapone Side Effects Report #5488311-2
Physician from JAPAN reported ENTACAPONE problem on Sept 19, 2007. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease, gastric ulcer, dyspepsia, constipation, haemorrhoids and was treated with ENTACAPONE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, concomitant disease progression, dysphagia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest, sputum retention, . ENTACAPONE dosage: 200MG QID (800MG/DAY). During the same period patient was treated with FAMOTIDINE, SEVEN EP, MUCOSTA, EC DOPARL, MAGNESIUM OXIDE, LECICARBON, POSTERISAN. Patient was hospitalized. Patient died on 09/29/2007.
CONCOMITANT DISEASE PROGRESSION : Entacapone Side Effects Report #5501531-3
ENTACAPONE problem was reported by a Physician from JAPAN on Oct 23, 2007. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease, gastric ulcer, dyspepsia, constipation, haemorrhoids and was treated with ENTACAPONE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, concomitant disease progression, dysphagia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest, sputum retention, . ENTACAPONE dosage: 200MG QID (800MG/DAY). During the same period patient was treated with FAMOTIDINE, SEVEN EP, MUCOSTA, EC DOPARL, MAGNESIUM OXIDE, LECICARBON, POSTERISAN. Patient was hospitalized. Patient died on 09/29/2007.
CONCOMITANT DISEASE PROGRESSION : Neoral Side Effects Report #5441338-9
Consumer or non-health professional from JAPAN reported NEORAL problem on Aug 27, 2007. Female patient, 61 years of age, was diagnosed with dermatomyositis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: candidiasis, concomitant disease progression, interstitial lung disease, pancreatitis, psychotic disorder, . NEORAL dosage: unknown. During the same period patient was treated with PREDNISOLONE, SIVELESTAT, STEROIDS NOS. Patient died.
CONCOMITANT DISEASE PROGRESSION : Neoral Side Effects Report #5441339-0
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on Aug 27, 2007. Female patient, 61 years of age, was diagnosed with dermatomyositis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: candidiasis, concomitant disease progression, interstitial lung disease, pancreatitis, psychotic disorder, . NEORAL dosage: unknown. During the same period patient was treated with PREDNISOLONE, SIVELESTAT, STEROIDS NOS. Patient died.
CONCOMITANT DISEASE PROGRESSION : Cyclosporine Side Effects Report #5413661-5
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Aug 09, 2007. Female patient, 61 years of age, was diagnosed with dermatomyositis and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: candidiasis, concomitant disease progression, interstitial lung disease, psychotic disorder, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISOLONE, SIVELESTAT, STEROIDS NOS. Patient died.
CONCOMITANT DISEASE PROGRESSION : Lotrel Side Effects Report #5375889-2
LOTREL problem was reported by a Physician from UNITED STATES on June 21, 2007. Female patient, 68 years of age, weighting 171.3 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, concomitant disease progression, diabetic nephropathy, dyspnoea, dyspnoea exertional, fluid overload, oedema, orthopnoea, proteinuria, . LOTREL dosage: unknown. During the same period patient was treated with LABETALOL, LASIX. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Enbrel Side Effects Report #5386606-4
Health Professional from UNITED KINGDOM reported ENBREL problem on July 05, 2007. Male patient was diagnosed with ankylosing spondylitis, depression, hypertension, immunosuppression, hypercholesterolaemia, diabetes mellitus, platelet aggregation inhibition and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: blister, concomitant disease progression, fall, head injury, joint stiffness, neutropenic sepsis, renal failure acute, skin ulcer, vomiting, . ENBREL dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, ATENOLOL, FLOXACILLIN, RANITIDINE, METHOTREXATE, SIMVASTATIN, GLICLAZIDE, CLOPIDOGREL. Patient was hospitalized. Patient died on 05/18/2007.
CONCOMITANT DISEASE PROGRESSION : Lotrel Side Effects Report #5375889-2
LOTREL problem was reported by a Physician from UNITED STATES on June 21, 2007. Female patient, 68 years of age, weighting 171.3 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, concomitant disease progression, diabetic nephropathy, dyspnoea, dyspnoea exertional, fluid overload, oedema, orthopnoea, proteinuria, . LOTREL dosage: unknown. During the same period patient was treated with LABETALOL, LASIX. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Enbrel Side Effects Report #5386606-4
Health Professional from UNITED KINGDOM reported ENBREL problem on July 05, 2007. Male patient was diagnosed with ankylosing spondylitis, depression, hypertension, immunosuppression, hypercholesterolaemia, diabetes mellitus, platelet aggregation inhibition and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: blister, concomitant disease progression, fall, head injury, joint stiffness, neutropenic sepsis, renal failure acute, skin ulcer, vomiting, . ENBREL dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, ATENOLOL, FLOXACILLIN, RANITIDINE, METHOTREXATE, SIMVASTATIN, GLICLAZIDE, CLOPIDOGREL. Patient was hospitalized. Patient died on 05/18/2007.
CONCOMITANT DISEASE PROGRESSION : Enbrel Side Effects Report #5644609-6
ENBREL problem was reported by a Physician from UNITED KINGDOM on Feb 20, 2008. Male patient, weighting 143.3 lb, was diagnosed with rheumatoid arthritis, cardiac failure congestive, myocardial ischaemia, blood cholesterol increased, pain and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cardiac failure acute, concomitant disease progression, myocardial ischaemia, . ENBREL dosage: unknown. During the same period patient was treated with FUROSEMIDE, METOPROLOL TARTRATE, METOPROLOL TARTRATE, PERINDOPRIL, SIMVASTATIN. Patient died on 09/21/2007.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5581337-X
Physician from UNITED STATES reported ZOLEDRONIC ACID problem on Jan 03, 2008. Male patient, 79 years of age, was diagnosed with osteoporotic fracture, deep vein thrombosis and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: cellulitis, chills, concomitant disease progression, debridement, leg amputation, malaise, osteomyelitis, pyrexia, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, LOVENOX, CALCIUM CARBONATE, VITAMIN D. Patient was hospitalized and became disabled. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5565100-1
ZOLEDRONIC ACID problem was reported by a Physician from DENMARK on Dec 18, 2007. Male patient, 80 years of age, weighting 196.7 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cerebrovascular accident, concomitant disease progression, neuralgia, . ZOLEDRONIC ACID dosage: 5MG, ONCE YEARLY. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM CARBONATE, VITAMIN D. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Zoledronic Side Effects Report #5565101-3
Physician from DENMARK reported ZOLEDRONIC ACID problem on Dec 18, 2007. Female patient, 65 years of age, weighting 103.6 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: blood electrolytes abnormal, chronic obstructive pulmonary disease, concomitant disease progression, dehydration, respiratory failure, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, VITAMIN D, SPIRIVA. Patient was hospitalized. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Neoral Side Effects Report #5521666-9
NEORAL problem was reported by a Physician from ITALY on Nov 15, 2007. Male patient, 58 years of age, weighting 224.9 lb, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis, cerebral haemorrhage, concomitant disease progression, fungal sepsis, graft ischaemia, multi-organ failure, renal failure acute, . NEORAL dosage: 790 MG/DAILY. During the same period patient was treated with METHYLPREDNISOLONE. Patient was hospitalized. Patient died on 09/10/2007.
CONCOMITANT DISEASE PROGRESSION : Neoral Side Effects Report #5491502-8
Physician from ITALY reported NEORAL problem on Oct 16, 2007. Male patient, 58 years of age, weighting 224.9 lb, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis, cerebral haemorrhage, concomitant disease progression, fungal sepsis, graft ischaemia, renal failure acute, . NEORAL dosage: 790 MG/DAILY. During the same period patient was treated with METHYLPREDNISOLONE. Patient was hospitalized. Patient died on 09/10/2007.
CONCOMITANT DISEASE PROGRESSION : Exjade Side Effects Report #5393322-1
EXJADE problem was reported by a Physician from SINGAPORE on July 16, 2007. Male patient, 16 years of age, weighting 100.3 lb, was diagnosed with haemosiderosis, hypothyroidism, hypogonadism and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: chest pain, cold sweat, concomitant disease progression, congestive cardiomyopathy, . EXJADE dosage: 1000 MG, QD. During the same period patient was treated with LEVOTHYROXINE, CALTRATE, TESTOSTERONE. Patient recovered.
CONCOMITANT DISEASE PROGRESSION : Exjade Side Effects Report #5393322-1
Physician from SINGAPORE reported EXJADE problem on July 16, 2007. Male patient, 16 years of age, weighting 100.3 lb, was diagnosed with haemosiderosis, hypothyroidism, hypogonadism and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: chest pain, cold sweat, concomitant disease progression, congestive cardiomyopathy, . EXJADE dosage: 1000 MG, QD. During the same period patient was treated with LEVOTHYROXINE, CALTRATE, TESTOSTERONE. Patient recovered.